Teva stock recovered Wednesday on surprisingly light guidance for 2026 following a decisive fourth-quarter beat.

Last week, the FTC issued a civil investigative demand, effectively a subpoena, to Teva. This demand compels the company to provide internal communications, analysis, and financial data related to the ...

Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well as ...